Anders H Berg1, Camille E Powe2, Michele K Evans3, Julia Wenger4, Guillermo Ortiz4, Alan B Zonderman3, Pirianthini Suntharalingam5, Kathryn Lucchesi4, Neil R Powe6, S Ananth Karumanchi7, Ravi I Thadhani8. 1. Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; ahberg@bidmc.harvard.edu rthadhani@mgh.harvard.edu. 2. Division of Endocrinology, Massachusetts General Hospital, Boston, MA; 3. Laboratory of Epidemiology and Population Sciences, National Institute on Aging, National Institutes of Health, Baltimore MD; 4. Division of Nephrology, Massachusetts General Hospital, Boston, MA; 5. Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; 6. Department of Medicine, San Francisco General Hospital and University of California, San Francisco, CA; 7. Division of Nephrology, Beth Israel Deaconess Medical Center, Boston, MA; Howard Hughes Medical Institute, Chevy Chase, MD. 8. Division of Nephrology, Massachusetts General Hospital, Boston, MA; ahberg@bidmc.harvard.edu rthadhani@mgh.harvard.edu.
Abstract
BACKGROUND: 24,25-Dihydroxyvitamin D [24,25(OH)2D] is a metabolite of 25-hydroxyvitamin D (25D). Blacks frequently have low total 25D without manifestations of vitamin D deficiency, suggesting that total serum 25D may incorrectly reflect vitamin D status in different racial groups. The ratio of serum 24,25(OH)2D to 25D [vitamin D metabolite ratio (VMR)] represents a new candidate biomarker for vitamin D status. METHODS: We measured 24,25(OH)2D3 and 25D3 by mass spectrometry in a random community cohort of black (n = 212) and white (n = 164) Americans to evaluate VMR as a marker for vitamin D status. We measured parathyroid hormone concentrations by immunoassay to compare VMR and 25D3 against a physiological indicator of vitamin D deficiency. RESULTS: Serum 24,25(OH)2D3 strongly correlated with 25D3 in both black and white study participants (r = 0.90, P < 0.001 and r = 0.86, P < 0.001 respectively). Blacks had lower mean 25D3 than whites [17.0 (7.8) vs 27.5 (11.3) ng/mL; 42.4 (19.5) vs 68.6 (28.2) nmol/L, P < 0.001] and lower mean 24,25(OH)2D3 [2.1 (1.3) vs 3.6 (2.0) ng/mL; 5.1 (3.1) vs 8.7 (4.8) nmol/L, P < 0.001]. In contrast to total 25D3 concentrations, mean VMR values were similar in blacks and whites [11.9 (4.0) vs 12.5 (3.4), P = 0.16, respectively] and were negatively correlated with parathyroid hormone concentrations in both races (rs = -0.26, P < 0.001, and rs = -0.25, P < 0.001, respectively). CONCLUSIONS: Our results provide further evidence that measurement of total 25D for assessment of vitamin D status in patients of African descent deserves reevaluation and suggest that alternative measures such as VMR should be considered.
BACKGROUND:24,25-Dihydroxyvitamin D [24,25(OH)2D] is a metabolite of 25-hydroxyvitamin D (25D). Blacks frequently have low total 25D without manifestations of vitamin D deficiency, suggesting that total serum 25D may incorrectly reflect vitamin D status in different racial groups. The ratio of serum 24,25(OH)2D to 25D [vitamin D metabolite ratio (VMR)] represents a new candidate biomarker for vitamin D status. METHODS: We measured 24,25(OH)2D3 and 25D3 by mass spectrometry in a random community cohort of black (n = 212) and white (n = 164) Americans to evaluate VMR as a marker for vitamin D status. We measured parathyroid hormone concentrations by immunoassay to compare VMR and 25D3 against a physiological indicator of vitamin D deficiency. RESULTS: Serum 24,25(OH)2D3 strongly correlated with 25D3 in both black and white study participants (r = 0.90, P < 0.001 and r = 0.86, P < 0.001 respectively). Blacks had lower mean 25D3 than whites [17.0 (7.8) vs 27.5 (11.3) ng/mL; 42.4 (19.5) vs 68.6 (28.2) nmol/L, P < 0.001] and lower mean 24,25(OH)2D3 [2.1 (1.3) vs 3.6 (2.0) ng/mL; 5.1 (3.1) vs 8.7 (4.8) nmol/L, P < 0.001]. In contrast to total 25D3 concentrations, mean VMR values were similar in blacks and whites [11.9 (4.0) vs 12.5 (3.4), P = 0.16, respectively] and were negatively correlated with parathyroid hormone concentrations in both races (rs = -0.26, P < 0.001, and rs = -0.25, P < 0.001, respectively). CONCLUSIONS: Our results provide further evidence that measurement of total 25D for assessment of vitamin D status in patients of African descent deserves reevaluation and suggest that alternative measures such as VMR should be considered.
Authors: Martin Kaufmann; J Christopher Gallagher; Munro Peacock; Karl-Peter Schlingmann; Martin Konrad; Hector F DeLuca; Rita Sigueiro; Borja Lopez; Antonio Mourino; Miguel Maestro; René St-Arnaud; Joel S Finkelstein; Donald P Cooper; Glenville Jones Journal: J Clin Endocrinol Metab Date: 2014-03-26 Impact factor: 5.958
Authors: Robin Taylor Wilson; James D Bortner; Alanna Roff; Arunangshu Das; Eric J Battaglioli; John P Richie; Jill Barnholtz-Sloan; Vernon M Chinchilli; Arthur Berg; Guodong Liu; Anna C Salzberg; Karam El-Bayoumy Journal: Transl Res Date: 2014-08-27 Impact factor: 7.012
Authors: Camille E Powe; Michele K Evans; Julia Wenger; Alan B Zonderman; Anders H Berg; Michael Nalls; Hector Tamez; Dongsheng Zhang; Ishir Bhan; S Ananth Karumanchi; Neil R Powe; Ravi Thadhani Journal: N Engl J Med Date: 2013-11-21 Impact factor: 91.245
Authors: Olivia Trummer; Stefan Pilz; Michael M Hoffmann; Bernhard R Winkelmann; Bernhard O Boehm; Winfried März; Thomas R Pieber; Barbara Obermayer-Pietsch; Wilfried Renner Journal: Clin Chem Date: 2013-01-14 Impact factor: 8.327
Authors: Ian H de Boer; Michael C Sachs; Michel Chonchol; Jonathan Himmelfarb; Andrew N Hoofnagle; Joachim H Ix; Robin A Kremsdorf; Yvonne S Lin; Rajnish Mehrotra; Cassianne Robinson-Cohen; David S Siscovick; Michael W Steffes; Kenneth E Thummel; Russell P Tracy; Zhican Wang; Bryan Kestenbaum Journal: Am J Kidney Dis Date: 2014-04-03 Impact factor: 8.860
Authors: Toni E Ziegler; Amita Kapoor; Neil C Binkley; Karen S Rice; Jeffrey Rogers; Clifford J Jolly; Jane E Phillips-Conroy Journal: Am J Primatol Date: 2018-12 Impact factor: 2.371
Authors: Charles Ginsberg; Leila R Zelnick; Geoffrey A Block; Glenn M Chertow; Michel Chonchol; Andrew Hoofnagle; Bryan Kestenbaum; Ian H de Boer Journal: Nephrol Dial Transplant Date: 2020-04-01 Impact factor: 5.992
Authors: Rosemary L Schleicher; Maya R Sternberg; Anne C Looker; Elizabeth A Yetley; David A Lacher; Christopher T Sempos; Christine L Taylor; Ramon A Durazo-Arvizu; Khin L Maw; Madhulika Chaudhary-Webb; Clifford L Johnson; Christine M Pfeiffer Journal: J Nutr Date: 2016-04-06 Impact factor: 4.798
Authors: Agnieszka Prytuła; Johan Vande Walle; Hans Van Vlierberghe; Jean-Marc Kaufman; Tom Fiers; Jo Dehoorne; Ann Raes Journal: Endocrine Date: 2015-10-03 Impact factor: 3.633
Authors: Kristen L Nowak; Traci M Bartz; Lorien Dalrymple; Ian H de Boer; Bryan Kestenbaum; Michael G Shlipak; Pranav S Garimella; Joachim H Ix; Michel Chonchol Journal: J Am Soc Nephrol Date: 2016-11-10 Impact factor: 10.121
Authors: Heyjun Park; Patsy M Brannon; Allyson A West; Jian Yan; Xinyin Jiang; Cydne A Perry; Olga V Malysheva; Saurabh Mehta; Marie A Caudill Journal: J Nutr Date: 2016-06-22 Impact factor: 4.798
Authors: Charles Ginsberg; Ronit Katz; Ian H de Boer; Bryan R Kestenbaum; Michel Chonchol; Michael G Shlipak; Mark J Sarnak; Andrew N Hoofnagle; Dena E Rifkin; Pranav S Garimella; Joachim H Ix Journal: Bone Date: 2017-11-16 Impact factor: 4.398
Authors: Zona Batacchi; Cassianne Robinson-Cohen; Andrew N Hoofnagle; Tamara Isakova; Bryan Kestenbaum; Kevin J Martin; Myles S Wolf; Ian H de Boer Journal: Clin J Am Soc Nephrol Date: 2017-08-02 Impact factor: 8.237